Congresses and Events

PCR London Valves Symposia: Extending treatment options to address evolving needs in TAVI

PCR London Valves Symposia
Advances in device technology can expand treatment options for transcatheter valve implantation from vascular access to cerebral embolic protection. Watch this symposia from PCR London Valves to understand how the ACURATE neo™ and LOTUS valves combined with high profile accessories can advance practice in key patient subsets.

Moving to a patient tailored TAVI: Dr Van Mieghem’s interview from PCR London Valves

Moving to a patient tailored TAVI
In this interview from PCR London Valves, Dr. Nicolas Van Mieghem (Erasmus Medical Center, Netherlands) discusses Boston Scientific offering and the importance of having 2 different valves types to help you delivering optimal TAVI results for patients.

Sentinel Cerebral Embolic Protection System, now Part of Boston Scientific´s TAVI Portfolio

Sentinel Cerebral Embolic Protection System
The SENTINEL cerebral protection system has demonstrated that reduces the risk of stroke during TAVI in the range of 63 – 78%. It is the only TAVI cerebral protection device commercially available and, to date, it has protected over 11,000 patients. See the symposia from PCR London Valves to learn more about the real-world European experience of cerebral protection.

SYNERGY™ - High-bleeding risk patients and DAPT: implementing the latest clinical evidence into real-world practice

Synergy at PCR
A symposium from EuroPCR 2018 dedicated to the latest clinical data and recent evidence updates, to understand how to relate trial data into real practice. Watch the video and learn more about the potential benefits of bioabsorbable polymer DES in high-bleeding risk patients, the SYNERGY™ design and ongoing DAPT studies.

Further Information